Summary
A bioRxiv preprint reports a nano-ring-assisted system for continuously regenerating peritoneal dialysate. In canine models, it reduced circulating uremic toxins by approximately 10%, while an improved version sustained removal for four hours.
A bioRxiv preprint describes a nano-ring-assisted device designed to continuously regenerate the fluid used in peritoneal dialysis. In a closed-loop canine model, the system reduced circulating uremic toxin levels by approximately 10%. An improved version sustained continuous toxin removal for 4 hours in an unanesthetized canine model.
The report, posted on September 21, 2026, presents a preclinical engineering study rather than a human clinical trial. Its proposed application is a portable or wearable artificial kidney system that could reduce the need for repeated replacement of fresh dialysate.
How the regenerative dialyzer works
Peritoneal dialysis uses the membrane lining the abdomen as a filtering interface. Dialysate placed in the abdominal cavity collects waste products from the blood and is normally removed and replaced. A regenerative system instead treats the used fluid so it can remain part of a closed circulation loop.
The researchers developed a nanoelectrokinetic dialyzer built around nano-ring meshes. Electrokinetic systems use an applied electric field to influence the movement of substances in fluid. The study examined several design factors affecting removal performance: mesh dimensions, the thickness of the nano-ring coating, the number of cascaded nano-rings and the orientation of fluid flow relative to the electric field.
The team first developed a single nano-ring dialyzer operating at 1.33 mL/min. It then increased the treatment capacity through parallel integration of multiple modules, reaching approximately 10 mL min/min as reported in the abstract. Cascading and parallelising the modules were intended to make the system scalable while maintaining continuous processing.
Results in canine models
In a canine model, the closed-loop system produced an approximately 10% reduction in circulating uremic toxin levels during continuous treatment. Uremic toxins are waste compounds that can accumulate when kidney function is severely impaired.
The researchers then modified the system to improve the biocompatibility of the regenerated dialysate. The revised design combined plate-type electrodes, activated carbon, bicarbonate buffering and UV-C treatment. In an unanesthetized canine model, this version maintained continuous toxin removal for 4 hours. Major hepatic and inflammatory markers remained within recoverable ranges during the experiment.
The abstract identifies the work as a canine-model study but does not report an animal count, a comparator or the individual toxins measured. The evidence therefore describes short-duration in-vivo operation of an experimental device, rather than clinical dialysis performance in people.
The authors present the results as a technological foundation for portable or wearable regenerative peritoneal dialysis. The main engineering significance is the combination of nano-ring separation, dialysate treatment and modular scaling in a closed-loop system. Longer-duration testing and studies in humans would be needed to determine whether the approach can provide safe and effective kidney replacement therapy.